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Oriol Turró-Garriga , Joan Vilalta-Franch , Course of depressive symptoms and associated factors
in people aged65+ in Europe: A two-year follow-up, Journal of Affective Disorders (2018), doi:
https://doi.org/10.1016/j.jad.2018.10.358
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service
to our customers we are providing this early version of the manuscript. The manuscript will undergo
copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please
note that during the production process errors may be discovered which could affect the content, and














 The prevalence of relevant depressive symptoms increased over the 2-year period  
 Factors associated with incidence were gender, self-rated health and loneliness 















Background: The epidemiology of depressive disorders presents notable differences among 
European countries. The objectives of the study are to determine the prevalence, incidence, 
persistence and remission rates of depressive symptoms and to identify risk factors and 
differences between four European regions. 
Method: Prospective cohort design using data from waves 5 and 6 (2013-15) of the Survey of 
Health, Ageing and Retirement in Europe. Sample size included 31,491 non-institutionalized 
adults aged 65+. Depressive symptoms were assessed using the EURO-D. 
Results: The prevalence of depressive symptoms (EURO-D ≥4) was 29.8% and 31.5%in waves 5 
and 6, respectively. The risk factors associated depressive symptoms were poorer self-rated 
health, loneliness, impairment in ADL, female gender and financial difficulties. Incidence was 
6.62 (99.9% CI: 6.61-6.63)/100 person-years and the persistence and remission rates were 9.22 
and 5.78, respectively. Regarding the differences between European regions, the incidence (4.93 
to 7.43) and persistence (5.14 to 11.86) rates followed the same ascending order: Northern, 
Eastern, Continental and Southern. The remission presented higher rates in the Eastern and 
Southern (6.60-6.61) countries than in the Northern and Continental (4.45-5.31) ones. 
Limitations: The EURO-D scale is unable to distinguish between clinically relevant depressive 
symptoms and major depression. 
Conclusion: The risk factors related to the incidence of depressive symptoms differed across 
European regions. In countries of eastern and southern Europe the most important predictors 
were female gender and impairment in ADL. Poorer self-rated health and older age were more 
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Southern (6.60-6.61) countries than in the Northern and Continental (4.45-5.31) ones. 
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were female gender and impairment in ADL. Poorer self-rated health and older age were more 















Depressive disorders are common and affect more than 40.2 million people across Europe, with 
a prevalence of 5.1% in women and 3.6% in men (major depression and dysthymia), and they 
account for 8.1% of all years lived with disability (WHO, 2017). Depression is also the main 
indicator associated with lower quality of life (Conde-Sala et al., 2017; Portellano-Ortiz et al., 
2018). 
The review studies indicate that prevalence rates for clinically relevant depressive symptoms in 
older adults vary widely (7.2-49.0%) due to the different instruments, criteria, settings and 
methodologies used to collect data (Djernes, 2006). Although major depressive episodes are less 
common in older age (1-4%), what is referred to as sub-clinical depression is a particularly relevant 
phenomenon (8-16%), (Alexopoulos, 2005; Blazer, 2003). 
In a recent study with a sample of people aged 65+ from 12 European countries, prevalence was 
12.6% for cases of depression and 15.2% for sub-threshold depression, assessed with the Geriatric 
Mental State Examination (GMS-AGECAT) (Braam et al., 2014). However, the WHO study of the 
European region (WHO, 2016) warned that due to increasing life expectancy the burden of 
depression will progressively shift towards older age groups, among whom risk factors for 
depression such as bereavement and comorbid health conditions are more frequent. 
Some of the most commonly used instruments to assess depressive symptoms are CES-D 
(Radloff, 1977), GDS-15 (Sheikh and Yesavage, 1986), and EURO-D (Prince et al., 1999), and they 
show higher prevalences than other instruments assessing only depressive disorders. Studies that 
have used the EURO-D scale to assess depressive symptoms in European countries have reported 
prevalence rates, between 17.8%-38.3% for the over-50s (Castro-Costa et al., 2007; Peytremann-
Bridevaux et al., 2008) and 15.8% -41.4% in people aged 65+ (Damian et al., 2013; Conde-Sala et al., 













financial difficulties, widowhood, fewer social activities and low educational level (Portellano-Ortiz 
et al., 2017). It is important to note that the prevalence of depressive symptoms varies according to 
geographical region, with rates being lower in northern Europe (Sweden, Denmark, The 
Netherlands) and higher in more southern countries (Italy, Spain, France), (Castro-Costa et al., 
2007). This variability across different geographical areas is supported by other studies that have 
highlighted the importance of social and cultural factors such as level of education, income and 
loneliness (Guerra et al., 2016; Ylli et al., 2016). 
Incidence rates for depressive disorders in Europe range between 3.4 and 4.2/100 person- years 
(Luppa et al., 2012a; Weyerer et al., 2013). Higher incidence has been associated with female 
gender, physical health problems, functional impairment, poor social networks and, in some 
studies, with older age (Weyerer et al., 2013). 
Persistence rates range between 23.0% and 61.0% (Comijs et al., 2015; Gallagher et al., 2013; 
Luppa et al., 2012a), the associated factors being chronic disease, functional impairment, female 
gender, a history of depression and younger age at onset. 
Remission rates are also variable (4.8%-60.0%) (Comijs et al., 2015; Houtjes et al., 2014; Luppa 
et al., 2012a), with the likelihood of remission being linked to less depression at baseline, less 
anhedonia and fewer neurovegetative symptoms at baseline (Andreescu et al., 2008), and better 
health and younger age (Kennedy et al., 1991) with respect to persistent cases. Remission has also 
been shown to be less likely among women (Barry et al., 2008). 
The general aim of this study was to determine the course of depressive symptoms in a sample 
of people aged 65+ from 14 European countries over a two-year period. The specific aims were: 1. 
To identify the variables associated with depressive symptoms and their prevalence. 2. To 
determine the incidence, persistence and remission rates and to identify predictor variables and 3. 















2.1. Study design 
This was a prospective population-based study using data from waves 5 and 6 of the Survey of 
Health, Ageing and Retirement in Europe (SHARE), (Börsch-Supan et al., 2013), corresponding to 
the years 2013 and 2015 respectively. The data analysed were for people aged 65+. The SHARE 
study provides information about sociodemographic variables, physical and mental health, 
quality of life, socioeconomic status and activities. This information was collected by means of a 
computer-assisted personal interview (CAPI) lasting around 90 minutes and conducted in the 
participant’s home. The analyzed waves include the most recent SHARE data. 
For the present study we considered countries for which longitudinal data were available in 
waves 5 and 6: Denmark, Sweden, Switzerland, Luxembourg, Austria, Germany, Belgium, France, 
Slovenia, Czech Republic, Estonia, Spain, Italy and Israel. Mean individual response rates with 
respect to the number of eligible participants in longitudinal samples were 69.4% in wave 5 and 
67.1% in wave 6. Response rates by country in the two waves (5 / 6) ranged from 57.9% / 48.0% 
in France to 85.0% / 79.2% in Estonia (Malter and Börsch-Supan, 2015, 2017). 
The sample for the present study comprised 23,201 older adults with complete data on the 
EURO-D in waves 5 and 6, and 31,491 people aged 65+ who were initially available in wave 5 
(Figure 1). 
2.2. Measures 
The SHARE data, variables and instruments considered in the present study were: 
• Sociodemographic data: Age (<75/≥75years), gender (male/female), marital status 
(married/unmarried) and years of schooling (<10 years/≥10 years). 














• Physical health: Subjective rating of health (Very good, Good/Fair, Poor), chronic diseases 
(heart disease, hypertension, cholesterol, stroke, diabetes, chronic lung disease, cancer, ulcer, 
Parkinson, fractures, dementia) (0-1/≥2) and impairment in basic and instrumental activities of 
daily living (ADL) (No/≥1). 
• Loneliness: Scores on a short loneliness scale (Hughes et al., 2004) comprising three items 
(lack companionship, feel left out, feel isolated) on which respondents indicate the frequency of 
the corresponding feeling; total score ranging from 3 to 9. The Cronbach’s alpha for the original 
scale was 0.72, and in the present study 0.76. A score above 3 is considered indicative of 
loneliness. 
 Depressive symptoms. Assessed using the EURO-D (Prince et al., 1999a, 1999b; Guerra et 
al., 2015), which comprises 12 items (depressive symptoms, pessimism, death wish, guilt, 
irritability, crying, fatigue, sleep problems, loss of interest and appetite, reduced ability to 
concentrate and capacity to enjoy things over the last month). Items require a yes/no response 
and the total score ranges from 0-12. The EURO-D was designed using items from other 5 
instruments: the GMS-AGECAT (Copeland et al, 1986), the SHORT CARE (Gurland et al., 1984), 
the CPRS (Åsberg et al., 1978), the CES-D (Radloff, 1977), and the ZSDS (Zung, 1965). 
Reliability and validity analyses were performed in 14 different European centers, showing 
appropriate psychometric yields. Internal consistency was measured using Cronbach alpha with 
values 0.74-0.80 with the CES-D, and 0.61-0.75 with the GMS and the SHORT-CARE. Regarding 
validity, Spearman correlations were 0.70-0.92 with the CES-D, 0.84 with the ZSDS, and 0.79 
with the SHORT-CARE (Prince et al., 1999a). 
The cut-off for clinically relevant depressive symptoms is ≥4, with a mean sensitivity of 74.8% 













was moderate (0.69), as in the present study (0.72). 
• Cognition. Specific items from the SHARE project were used to assess the cognitive status 
of participants, based on the items for immediate recall (range = 0-10), delayed recall (range = 0-
10), subtraction calculation skills (range = 0-5) and verbal fluency (range = 1-10). We created a 
combined scale including all these items, with a total score ranging between 0 and 35. This 
variable was dichotomized with respect to the mean score (≥15/<15 points). 
2.3. Statistical analysis 
We carried out a descriptive analysis with the whole sample, calculating frequencies for the 
clinical and sociodemographic variables in waves 5 and 6 and the associated depressive 
symptoms (EURO-D ≥4). The Chi-square test (χ2) was used to examine differences. The effect 
size for differences between proportions was assessed by means of Cramer’s V (V), the value of 
which depends on the degrees of freedom: df1 = small effect (≤0.10), medium effect (0.30), 
large effect (≥0.50); df3 = small effect (≤0.06), medium effect (0.17), large effect (≥0.29) (Cohen, 
1988). 
The same procedure was used to identify in wave 5 the variables associated with depressive 
symptoms and their prevalence in the four European regions, and to analyse the differences 
between them. The regions corresponded to country clusters based on the model of social 
welfare (Whelan and Maître, 2010; Hemerijck, 2013): Northern (Denmark, Sweden), Continental 
(Switzerland, Luxembourg, Austria, Germany, Belgium, France), Eastern (Slovenia, Czech 
Republic, Estonia) and Southern (Spain, Italy, Israel). 
In order to assess the relative impact of clinical and sociodemographic variables in the sample 
as a whole and in the four European regions we conducted multivariate binary logistic regression 













We created a new variable, ‘Depression status’, using data for the course of depressive 
symptoms (EURO-D (≥4) and comparing waves 5 and 6: ‘No depressive symptoms’ (in either 
wave), ‘Incidence’ (only in wave 6), ‘Persistence’ (in both waves) and ‘Remission’ (only in wave 
5).Incidence was defined as the number of persons with a new depressive episode divided by the 
total person-years at risk x 100 (Rothman, 2002).The confidence intervals (99.9% CI) were based 
on the exact Poisson distribution. Persistence and remission rates were expressed in the tables 
as the incidence rates (rate *100 persons-years), but we used percentages in the text in order to 
ease the comparison with other studies. 
A new series of multivariate binary logistic regression analyses was then conducted to 
identify the predictor variables in wave 5 of incidence and persistence vs. no depressive 
symptoms, and of remission vs. persistence. 
In all the multivariate logistic analyses all the variables were entered in a single step, 
indicating the odds ratio (OR) and the confidence interval (99.9 % CI). The effect size of the OR 
was interpreted as follows: small effect, <1.5; medium effect, 1.5-4.9; large effect, ≥5.0 (Chen et 
al., 2010). Differences between the OR of different European regions were examined by 
considering the z value, which implies comparison of the regression coefficients and the 




), (Altman and Bland, 2003). 
Prior to conducting the multivariate analyses we examined the collinearity of the clinical 
and sociodemographic variables by means of a linear regression analysis, taking the EURO-D 
score as the dependent variable. The results indicated moderate collinearity: Tolerance: 0.78- 
0.96; Variance inflation factor: 1.04-1.28; Condition index: 12.7 (Belsley, 1991). The ‘marital 
status’ variable was eliminated from the multivariate analyses as it showed a high degree of 
collinearity with loneliness and gender. 













individual weights (waves 5-6) provided by SHARE, which compensate for the unequal selection 
probabilities of the population parameters (Malter and Börsch-Supan, 2017). The level of 
statistical significance for hypothesis testing was <0.01 with 99.9% confidence intervals, 
according to the different analyses. Statistical analysis was performed using SPSS v24.0 for 




3.1. Differences between valid and missing participants 
From the total eligible sample of 31,491 participants aged 65+, 8,290 (26.3%) were lost to 
follow up for unknown reasons. At baseline (wave 5) and compared with cases that were 
followed up, lost cases were older, 81.3±7.7 vs 74.5±6.6 (t, p < 0.001, Cohen’s d = 0.94), had 
fewer years of schooling, 7.4±4.3 vs. 9.9±4.4 (t, p < 0.001, d = 0.57) and were more commonly 
female, 65.7 vs. 56.9% (χ2,p < 0.001, V = 0.04).More importantly, lost cases had poorer self- 
rated health, 68.2 vs. 45.2% (χ2,p < 0.001, V = 0.10), more depressive symptoms (EURO-D ≥4), 
56.4vs. 29.8% (χ2,p < 0.001, V = 0.13), poorer cognitive status(<15), 57.4 vs. 87.5% (χ2,p < 0.001, 
V = 0.13) and, especially, greater impairment in ADL (≥1), 55.6 vs. 16.7% (χ2,p < 0.001, V 
= 0.22). These data suggest that older age, more depressive symptoms, poorer health and 
deceased individuals may account for these cases being lost. 
3.2. Description of the sample 
The sample included 31,491 individuals at wave 5 and comprised 23,201 participants with 













D ≥4) increased slightly from 29.8% in wave 5 to 31.5% in wave 6 (χ2, p < 0.001, V = 0.02). The 
variables associated with the highest levels of depressive symptoms (>40%) in the two waves 
were impairment in ADL, poorer self-rated health, loneliness and financial difficulties. 
Percentages of depressive symptoms above the mean for the total sample were also associated 
with female gender, a higher number of chronic diseases, fewer years of schooling, not being 
married and older age. Differences between the two waves with respect to the presence of 
depressive symptoms showed a small effect size for all variables (V = 0.00-0.03). The complete 
data are shown in Table 1. 
Table 1 
3.3. Clinical and sociodemographic data for European regions in wave 5 
Across all the variables the most positive data corresponded to the Northern countries, and 
the most negative to the Eastern and Southern regions. The main differences between European 
regions were observed in relation to education (<10 years, Northern = 43.5%, Continental = 
39.3%, Eastern = 29.7%, Southern = 78.6%; p < 0.001, V = 0.38), financial difficulties (Northern = 
14.2%, Continental = 21.9%, Eastern = 46.8%, Southern = 54.4%; p < 0.001, V = 0.34) and 
cognition (<15), (Northern = 42.6%, Continental = 47.1%, Eastern = 48.8%, Southern = 77.8%; p < 
0.001, V = 0.30).The complete data are shown in Supplementary Table 1. 
3.4. Depressive symptoms and the associated variables for European regions in wave 5 
Using the cut-off of ≥4 on the EURO-D the prevalence of depressive symptoms by region was 
as follows: 16.8%, Northern; 27.3%, Continental; 25.4%, Eastern; 36.2%, Southern. 
In all four regions the variables associated with more depressive symptoms were poorer self-
rated health (V = 0.24-0.35), loneliness (V = 0.22-0.31), impairment in ADL (V = 0.18-0.32), 













0.22), marital status (V = 0.07-0.17). In all European regions, widowers had higher depression 
rates. However, the prevalence of depressive symptoms varied considerably across European 
regions, the rate being much lower in the North and higher in the South. 
Comparison of these two regions also showed a difference of more than 20% on some 
variables, namely greater impairment in ADL (33.9%), not being married (25.7%), female gender 
(25.1%), a higher number of chronic diseases (24.3%), greater loneliness (22.9%) and older age 
(20.9%). The complete data are shown in Table 2. 
Table 2 
3.5. Multivariate binary logistic regression: Variables related to depressive symptoms 
For the sample as a whole the variables most strongly associated with depressive symptoms 
(EURO-D, ≥4) were poorer self-rated health, loneliness, impairment in ADL, female gender and 
financial difficulties, this being the case for both waves 5 and 6. In wave 6 the only variable with 
a higher OR was poorer self-rated health, and female gender also became more relevant. 
In terms of the variables associated with depressive symptoms across the four regions, the 
southern countries had the highest OR with respect to impairment in ADL, loneliness, female 
gender, financial difficulties and chronic diseases. The Eastern region had the highest OR for 
poorer cognition and older age, the Northern countries had the highest OR for self-rated health, 
and the Continental countries the highest OR for less schooling. 
In wave 6 it was the Eastern countries that had the highest OR for impairment in ADL, 
loneliness, female gender, poorer cognition and chronic diseases. The Continental region had 
the highest OR for financial difficulties and less schooling, the Southern region had the highest 
OR for self-rated health, and the Northern countries had the highest OR for older age. The 














3.6. Depression status: No depressive symptoms, incidence, persistence and remission 
The variable ‘depression status’, established by comparing unweighted data for cases in 
waves 5 and 6, yielded the following rates: No depressive symptoms, 61.2%; incidence, 12.3%; 
persistence, 15.6%; remission, 10.8%. 
Figure 1 shows the selection of cases (wave 5) and their distribution across the four groups 
considered in wave 6. It can be seen that a higher proportion of cases were lost from the 
‘depressive symptoms’ group. Based on the number of new cases in wave 6 and the total 
person-years at risk, the incidence rate using weighted data was 6.62/100 person-years (99.9% CI 
Poisson: 6.61-6.63). 
Figure 1 
3.7. Predictors of incidence, persistence and remission in wave 5 
We conducted three multivariate binary logistic regression analyses in order to identify 
predictors (wave 5) of incidence, persistence and remission. 
Incidence vs. no depressive symptoms. In the whole sample the strongest predictors of 
incidence were female gender (OR: 1.78), poor self-rated health (OR: 1.67) and loneliness (OR: 
1.63).Regarding the differential predictors of incidence between the four European regions were 
as follows: Southern: female gender, loneliness, impairment in ADL, poorer self- rated health, 
older age and less schooling; Eastern: impairment in ADL and female gender; Continental: 
chronic diseases, older age, financial difficulties and poorer cognition, financial difficulties; 
Northern: poorer self-rated health, older age and chronic diseases (Table 4). 
Persistence vs. no depressive symptoms. The predictors of persistence in the whole sample 
had higher OR than did the predictors of incidence, this being the case for all the variables. 
The strongest predictors of persistence were poorer self-rated health, loneliness, impairment 













differences by region, the southern countries continued to yield high OR for impairment in ADL, 
loneliness, female gender, poorer self-rated health and older age, and also in chronic diseases 
and economic difficulties. In the Eastern region the highest OR corresponded to impairment in 
ADL, female gender, poorer cognition and older age, and in the Northern countries to poorer 
self-rated health, economic difficulties and older age. In the Continental region, the differential 
predictor was less schooling, and with greater similarity of the variables with respect to the 
global OR (Table 4). 
Remission vs. persistence. The mean baseline score on the EURO-D was lower among cases of 
remission compared with those showing persistence (4.95±1.2 vs. 5.83±1.7; p < 0.001, d = 0.58). 
The strongest predictors of remission in the total sample were better self-rated health (OR: 1.80) 
and male gender (OR: 1.51). In terms of differences across the four regions, the strongest 
predictors of remission by region were: Eastern: male gender, no impairment in ADL, better self-
rated health, more years of schooling and better cognition; Southern: no impairment in ADL, no 
loneliness, fewer chronic diseases and better cognition; Continental: better self-rated health, 
male gender and no financial difficulties; Northern: no financial difficulties and younger age 
(Table 4). 
Supplementary tables 2and 3 show, for each country, the variables associated with 




















4.1. Factors associated with the prevalence of depressive symptoms 
Regarding the first study aim, the multivariate analyses showed that the main variables 
associated with more depressive symptoms were poorer self-rated health, loneliness, 
impairment in ADL, female gender and financial difficulties. 
The relationship between self-rated health and depression has been studied in various 
cultural contexts: Australia, Mexico, USA and Europe (Ambresin et al., 2014; Bustos-Vázquez et 
al., 2017; Jang et al., 2012; Portellano-Ortiz et al., 2017), and as in our analysis this variable has 
been shown to be a strong predictor of depressive symptoms (Ambresin et al., 2014). 
Regarding loneliness, studies have reported an association with more depressive symptoms 
(Harris et al., 2006) and also with a more unfavourable course (Holvast et al., 2015; Houtjes et 
al., 2014). Functional impairment is one of the factors that has been most strongly linked to 
depression (Beekman et al, 2001; Djernes et al., 2006; Pagán-Rodríguez and Pérez, 2012), and in 
line with our results some authors have reported an association that is even stronger than that 
between depression and chronic diseases (Braam et al., 2005). Our finding that female gender is 
an important predictor of depressive symptoms is also consistent with a number of previous 
studies (Beekman et al., 2001; Djernes et al.; 2006; Zunzunegui et al., 2007). The relevance of 
chronic diseases and of all aspects of physical health has also been widely reported (Beekman et 
al., 2001; Hegeman et al., 2017; Ylli et al., 2016). Although our analysis suggested that financial 
difficulties was also an important factor in relation to depression, this variable has been less 
often cited in previous research (Blazer, 2003; Portellano-Ortiz et al., 2017; Ylli et al., 2016). 
Poorer cognitive status, fewer years of schooling and older age are variables of less relevance 













(Kuchibhatla et al., 2012) and to persistent depression (Gallagher et al., 2013). 
More years of education has been associated with less depression and may play a protective 
role (Ladin, 2008), although in our multivariate analyses its effect overlaps with that of other 
variables such as financial difficulties or cognition. Age was not a relevant factor in our analyses, 
possibly because, as shown by other studies (Blazer, 2003; Büchtemann et al., 2012), the effect 
of age disappears or is inconsistent when other variables such as health are controlled for. 
4.2. Prevalence rates of depressive symptoms 
In our study, the mean prevalence of depressive symptoms in the 14 countries was 29.8% 
(14.5-39.0) and 31.5% (15.5-39.2) in waves 5 and 6, respectively. These rates are concordant 
with previous studies that have used the EURO-D (Castro-Costa et al., 2007; Ladin et al., 2010; 
Portellano-Ortiz et al., 2017).  
Other instruments for the detection of depressive symptoms in European studies provide similar 
results. The Center for Epidemiologic Depression Scale, CES-D (Radloff, 1977), with a cut-off point 
≥16 / 20, showed prevalences ranging between 12.9% (Beekman et al., 2001) and 38.0% (Luppa et 
al., 2012a). The short version of the Geriatric Depression Scale, GDS (Sheikh and Yesavage, 1986), 
with a cut-off point ≥ 6/15, showed a prevalence of 18.8% (Harris et al., 2006). 
In the review studies, the prevalence data for depressive symptomatology, using these 
instruments, vary enormously, between 7.2 and 49.0% (Djernes, 2006), or 4.5-37.4 in ≥75 years 
(Luppa et al., 2012b). These differences in the results can be due to several aspects: setting 
(community, residences), gender, and differences between countries and cultures. 
When using categorical diagnostic criteria such as the DSM-IV, the mean prevalence for all 
depressive disorders is lower, 8.0% (6.3-9.6) in ≥ 65 years, (Andreas et al., 2017) or 7.2% (4.6-













4.3. Incidence, persistence and remission rates for depressive symptoms 
Regarding the second study aim, the incidence of depressive symptoms was 13.2% (6.62/100 
person-years at risk),a similar figure to that reported in reviews of European countries, 6.8 
(Büchtemann et al., 2012) and 6.6 (Chang-Quan et al., 2010), although it should be noted that 
there is considerable variation (between 1.4 and 14.1%) across studies (Beekman et al., 2001; 
Harris et al., 2006; Luppa et al., 2012a).The three predictors identified in our study are supported 
by previous research: female gender (Beekman et al., 2001; Büchtemann et al., 2012; Luppa et 
al., 2012a), poorer health (Beekman et al., 2001; Harris et al., 2006; Geerlings et al., 2000) and 
loneliness or poor social networks (Beekman et al., 2001; Luppa et al., 2012a). 
Persistence in our analysis was 18.3%, a rate lower than previously reported in European 
studies with clinical samples (23.0-61.2%) (Comijs et al., 2015; Gallagher et al., 2013; Luppa et 
al., 2012a). In this respect, it should be noted that we used a population sample and included all 
participants, regardless of whether they had clinically relevant symptoms of depression at 
baseline. The most important predictor of persistence in our study was poorer self-rated health, 
a finding that has been widely reported in the literature (Alpass and Neville, 2003; Ambresin et 
al., 2014; Chang-Quan et al., 2010; Guthrie et al., 2016). Previous studies also support the 
relevance of loneliness (Holvast et al., 2015; Houtjes et al., 2014), female gender, impairment in 
ADL and financial difficulties (Gallagher et al., 2013). 
The remission rate in our study was 11.5%, a figure towards the low end of the reported 
range (12.7-60.0%), (Comijs et al., 2015; Holvast et al., 2015; Luppa et al., 2012a). As in other 
studies, the likelihood of remission was associated with less chronic diseases (Hegeman et al., 
2017) less functional deficits (Geerlings et al., 2000) and male gender (Barry et al., 2008). A lower 
baseline score on the depressive symptoms compared with that for persistent cases was also a 













4.4. Differences in rates across European regions 
Regarding the third study aim, the prevalence of depressive symptoms was higher in the 
Southern region (36.2%) and lower in Northern countries (16.8%), a finding that reflects previous 
studies using the EURO-D (Castro-Costa et al., 2007; Ladin et al., 2010; Portellano- Ortiz et al., 
2017). These consistent results suggest that further work may be required to explore the 
possible influence of differences in the expression of depression in different cultures (Guerra et 
al., 2016; Ylli et al., 2016). 
The incidence rate was lowest in Northern countries and highest in the Southern region; the 
Continental and Eastern regions yielded a similar, intermediate rate. Although there are fewer 
studies of the incidence of depression in older adults, our results are consistent with other 
reports in European countries (Büchtemann et al., 2012; Chang-Quan et al., 2010). 
However, we have found no studies that specifically examined incidence rates among older 
adults from countries in the Eastern region. In a study that examined the incidence of DSM-IV 
major depression across all ages the authors reported a cumulative 12 months’ incidence of 
4.2% in Slovenia — below the lower bound in the present study — and 5.9% in Estonia, within 
the range of our data (King et al., 2008). 
Our results for persistence follow the same pattern as those for incidence, namely lowest in 
the Northern countries, highest in the Southern region and a similar, intermediate rate in the 
Continental and Eastern regions. The overall rate was lower than that reported in other 
European studies (range between 23.0% and 61.2%) that used different assessment criteria and 
instruments (Luppa et al., 2012a; Geerlings et al., 2000; Harris et al., 2006). In the study by 
Gallagher et al. (2013), using the EURO-D, the highest persistence rates corresponded to 














Interestingly, the remission rate was also highest in the Southern region, followed in 
decreasing order by the Eastern, Continental and Northern regions. These data suggest the need 
for a more detailed analysis of whether depressive symptoms are more widespread but less 
intense in the Southern region, in comparison with northern European countries. 
There is very little research on remission from depression in Europe. The study by Luppa et al. 
(2012a), in Germany, found no baseline characteristics that could predict whether a case would 
remit or persist. In a study of older adults in The Netherlands, Comijs et al. (2015) reported that 
minor depression at baseline was associated with a higher remission rate, a finding consistent 
with our data. 
4.5. Differences in predictors of depression across European regions 
In the overall comparison of predictors of incidence and persistence, countries from the 
Eastern and Southern regions had higher OR on a greater number of factors. The OR for female 
gender was highest in these two regions. Previous research has linked gender differences in 
mental disorders to the traditional female role, which is more common in Spain and Italy, 
especially among people over 65, whereas the gender difference was less marked in younger 
cohorts (Seedat et al., 2009). 
Impairment in ADL was also more strongly associated with depressive symptoms in countries 
from eastern and southern Europe. Functional impairment has previously been linked to higher 
levels of depression (Braam et al., 2014, Hajek and König, 2016), and among people with self-
reported disability, higher levels of depression were reported in Italy, France, 
Spain and Belgium, and lower levels in Switzerland, Sweden and Denmark (Pagán-Rodríguez and 
Pérez, 2012). 
Loneliness was strongly correlated with depressive symptoms and was a strong predictor 













levels of loneliness among older adults in southern and eastern European countries (van Tilburg 
and Dykstra, 2008). It is possible that in southern European societies, where the family has 
traditionally been an important source of support and older people are less likely to live alone 
(Zunzunegui et al., 2001; Daatland, 2011), the experience of loneliness when this support is lost 
or absent produces a greater depressive effect. In general, in Hispanic-Latin culture, loneliness 
causes a more negative appreciation of the self-health status, and a study reported more 
depressive symptoms together with loneliness in Hispanic people than in non-Hispanic people 
(Russell and Taylor, 2009). 
The highest OR for self-rated health corresponded to the Northern countries. The relationship 
this suggests between poorer self-rated health and more depressive symptoms is surprising 
given that perceived health was better in the Northern region. A previous European study found 
that self-rated health was better in Switzerland, Denmark and Sweden, and worse in Spain and 
Italy (Verropoulou, 2009), and yet in our multivariate analysis the OR for perceived health as a 
predictor of depression was higher for the Northern than for the Southern region. A question 
this raises is whether people in Northern countries are more sensitive to changes in perceived 
health. 
Differences were smaller for the remaining predictors, although it should be noted that 
chronic disease was a relevant factor with regard to incidence in the Continental region and 
persistence in the Southern region. Financial difficulties were a relevant predictor of persistence 
in southern European countries, while poorer cognition was a predictor of persistence in the 
Eastern region. Finally, less schooling was a risk factor for all regions except the Northern 
countries. 
With respect to remission, the relevant factors were male gender and better self-rated health, 













lack of studies on remission from depression in Europe prevents comparisons with the present 
results. 
The existence of worse indicators of depression in Eastern and Southern European 
countries may be related to the fact that they have less generous welfare state models. These 
countries rely more on the family to provide the older relatives with the required assistance and 
financial support. Nowadays, structural changes, the higher prevalence of smaller families, and 
the fact that most women work outside their homes, may hamper the capacity of the families to 
appropriately cover the needs of their older relatives. 
 
5. Conclusions, strengths and limitations 
Our results highlight important differences between European regions, especially between 
North and South Europe. The rates of depressive symptoms cannot be explained by individual 
factors alone, and cultural and socioeconomic aspects, according to the different welfare 
models, may have also a relevant role. The results of the study highlight the need for countries, 
especially in Eastern and Southern Europe, to provide greater support, resources and social 
benefits to the elderly, mainly those who live in situations of loneliness. 
This study has also many strengths, such as the fact that we analyzed the main indicators of 
depressive symptomatology, the prevalence, the incidence, the persistence and the remission 
using a longitudinal design; The size of the sample, representing 51,849.293 individuals 
(Weighted data); The amplitude of the sample with participants from 14 European countries, 
with an analysis of the differences between them, and the main variables associated with 
depressive symptoms. The instrument used to evaluate depressive symptoms is the same in all 













harmonized and homogeneous protocol. 
However, the study has a number of limitations. The first is that the EURO-D is unable to 
distinguish between clinically relevant depressive symptoms and cases of major depression. 
Second, the lack of studies reporting incidence and persistence rates for countries in the Eastern 
region, and for remission rates across all Europe as a whole prevents an adequate comparison of 
the present data. Third, the differences between European regions in terms of the variables that 
were found to be predictors of the incidence and persistence of depression requires more 
detailed analysis in order to explore the possible influence of cultural and socioeconomic factors, 
including how depression is expressed, or even differences in biological risk factors. Fourth, we 
could not rule out a selection bias effect due to the withdraw between wave 5 and 6 among the 
association between factors and incidence, persistence and remission.  And fifth, as in many 
longitudinal studies, there was a significant number of missing participants between the two 
waves. In this case it was mainly related to older age, health problems and the greater presence 
of depressive symptoms, which may suggest that the figures obtained regarding the indicators 
of depressive symptoms may have been underestimated. 
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Table 1  
Clinical and sociodemographic characteristics and depressive symptoms. Waves 5-6 (2013-15)  
  Characteristics Depressive symptoms. EURO-D (≥4), % 
  Waves 5 / 6  Wave 5 Wave 6  Differences  
  n = 23,201 6134, 29.8% 6480, 31.5% χ2 (df1)p V  
 
Age, % 
 65-74 57.0 / 46.4 26.4 25.5 < 0.001 0.01  
 ≥75  43.0 / 53.6 34.4 36.6 < 0.001 0.02 
 χ2 (df = 1), p, V < 0.001, 0.11 < 0.001, 0.09 < 0.001, 0.12   
Gender, %  
 Male 43.1 / 43.1 19.6 21.6 < 0.001 0.03  
 Female 56.9 / 56.9  37.6 38.9 < 0.001 0.01 
 χ2 (df = 1), p, V 1.000, 0.00 < 0.001, 0.19 < 0.001, 0.18    
Marital status, % 
 Married 58.3 / 56.1 26.2 27.1 < 0.001 0.00 
 Widowed 28.2 / 30.4 38.6 42.1 < 0.001 0.04 
 Separated / Divorced  7.9 /   7.9 27.9 28.6 < 0.001 0.00 
 Never married   5.6 /   5.6 27.5 24.5 < 0.001 0.03 
 χ2 (df = 3), p, V < 0.001, 0.02 < 0.001, 0.09 < 0.001, 0.11  
Schooling, %  
 ≥10 years 46.7 / 46.7 22.4 25.0 < 0.001 0.03 
 <10 years 53.3 / 53.3 36.5 37.4 < 0.001 0.01 
 χ2 (df = 1), p, V 1.000, 0.00 < 0.001, 0.15 < 0.001, 0.13  
Financial difficulties, %  
 None 66.2 / 69.7 22.9 25.3 < 0.001 0.03 
 Difficulty 33.8 / 30.3 42.2 44.0 < 0.001 0.02 
 χ2 (df = 1), p, V < 0.001, 0.04 < 0.001, 0.20 < 0.001, 0.19  
Loneliness, % 
 No 56.3 / 52.5 18.7 19.2 < 0.001 0.00  
 Yes 43.7 / 47.5 44.1 44.7 < 0.001 0.00  
 χ2 (df = 1), p, V < 0.001, 0.04 < 0.001, 0.28 < 0.001, 0.28  
Self-rated health, % 
 Very good, Good 54.8 / 52.1 16.1 16.9 < 0.001 0.01 
 Fair, Poor 45.2 / 47.9 46.5 47.3 < 0.001 0.00 
 χ2 (df = 1), p, V < 0.001, 0.03 < 0.001, 0.33 < 0.001, 0.33 
Chronic diseases, % 
 0-1 56.6 / 56.7 24.0 26.4 < 0.001 0.03 
 ≥2 43.4 / 43.3 37.4 38.2 < 0.001 0.00  
 χ2 (df = 1), p, V < 0.001, 0.00 < 0.001, 0.14 < 0.001, 0.13  
ADL impairment, % 
 No 83.3 / 79.2 24.3 25.3 < 0.001 0.01 
 ≥1 16.7 / 20.8 57.4 55.1 < 0.001 0.02 
 χ2 (df = 1), p, V < 0.001, 0.05 < 0.001, 0.27 < 0.001, 0.26 
Cognition, %  
 ≥15  42.6 / 41.0 20.8 21.2 < 0.001 0.00 
 <15 57.4 / 59.0 36.1 38.1 < 0.001 0.02 
 χ2 (df = 1), p, V < 0.001, 0.01 < 0.001, 0.17 < 0.001, 0.18 
 
Note. Weighted data. χ2 = Chi-square test. df = degrees of freedom. Effect size: V = Cramer’s (df1= small: 
≤0.10, medium: 0.11-0.49, large: ≥0.50). Medium and large effect sizes are shown in bold.  













Table 2  
Depressive symptoms and clinical and sociodemographic data in European regions. Wave 5 (2013) 
 Northern Continental Eastern Southern Differences 
n  3627  8696 5801 5077 χ2(df3 )p V 
 
EURO-D, mean (SD) 1.8 (1.8) 2.4 (2.0) 2.4 (2.1) 3.0 (2.5) < 0.001 0.02* 
 ≥4, % 16.8 27.3 25.4 36.2 < 0.001 0.11 
Age, %     
 65-74 13.8 24.7 20.7 31.7 < 0.001 0.10 
 ≥75 21.4 30.6 34.1 42.3 < 0.001 0.13 
 χ2 (df = 1), p, V < 0.001, 0.10 < 0.001, 0.06 < 0.001, 0.15 < 0.001, 0.11 
Gender, %       
 Male  11.1 18.5 15.1 23.0 < 0.001 0.08 
 Female 21.4 33.9 32.6 46.5 < 0.001 0.14 
 χ2 (df = 1), p, V < 0.001, 0.14 < 0.001, 0.17 < 0.001, 0.20 < 0.001, 0.24 
Marital status, %        
 Married 15.1 24.0 20.2 31.6 < 0.001 0.10 
 Widowed 20.9 33.8 34.3 49.4 < 0.001 0.17 
 Separated /Divorced 18.8 27.8 27.1 34.7 < 0.001 0.08 
 Never married 12.0 28.4 25.3 28.3 < 0.001 0.08 
 χ2 (df = 3), p, V <0.001,0.07 < 0.001, 0.10 < 0.001, 0.15 < 0.001, 0.17 
Schooling, %       
 ≥10 years 13.7 22.5 21.3 24.1 < 0.001 0.05 
 <10 years 20.7 34.7 35.3 39.5 < 0.001 0.08 
 χ2 (df = 1), p, V <0.001,0.09 < 0.001, 0.13 < 0.001, 0.15 < 0.001, 0.13 
Financial diffic. %  
 None 14.2 23.4 19.6 24.2 < 0.001 0.06 
 Difficulty 31.0 39.6 31.9 45.3 < 0.001 0.08 
 χ2 (df = 1), p, V < 0.001, 0.16 < 0.001, 0.15 < 0.001, 0.14 < 0.001, 0.22 
Loneliness, %  
 No  10.1 17.8 15.3 22.1 < 0.001 0.08 
 Yes 29.1 40.5 34.6 52.0 < 0.001 0.13 
 χ2 (df = 1), p, V < 0.001, 0.24 < 0.001, 0.25 < 0.001, 0.22 < 0.001, 0.31 
Self-rated health, %        
 Very good, Good  9.8 15.6 15.1 18.4 < 0.001 0.06 
 Fair, Poor  36.2 43.2 36.2 52.6 < 0.001 0.11 
 χ2 (df = 1), p, V < 0.001, 0.31 < 0.001, 0.31 < 0.001, 0.24 < 0.001, 0.35 
Chronic diseases, %        
 0-1 10.9 17.6 16.9 21.1 < 0.001 0.06 
 ≥2 21.5 33.7 30.4 45.8 < 0.001 0.14 
 χ2 (df = 1), p, V < 0.001, 0.14 < 0.001, 0.18 < 0.001, 0.15 < 0.001, 0.25 
ADL impairment, %  
 <1  14.3 22.6 20.1 29.0 < 0.001 0.09 
 ≥1 36.2 50.6 52.1 70.1 < 0.001 0.20 
 χ2 (df = 1), p, V < 0.001, 0.18 < 0.001, 0.23 < 0.001, 0.27 < 0.001, 0.32 
Cognition, %  
 ≥15  13.0 21.7 18.0 20.9 < 0.001 0.05 
 <15 21.0 33.7 33.1 39.9 < 0.001 0.09 
 χ2 (df = 1), p, V < 0.001, 0.11 < 0.001, 0.13 < 0.001, 0.17 < 0.001, 0.16 
 
Note. Weighted data. χ2 = Chi-square test. df = degrees of freedom. Effect size: V = Cramer’s (df1 = small: 
≤0.10, medium: 0.11-0.49, large: ≥0.50; df3 = small: ≤0.06, medium: 0.07-0.28, large: ≥0.29). Medium and 
large effect sizes are shown in bold. * F ANOVA, Eta squared. 
EURO-D (≥4) = Depression scale. European Countries = Northern (Denmark, Sweden), Continental (Switzerland, 















Multivariate binary logistic regression models. Variables related to depressive symptoms (EURO-D ≥4) 
  All Cases  Northern Continental Eastern Southern 
 n 23.201 3627  8696 5801 5077  
  OR 99.9% CI OR 99.9% CI OR 99.9% CI OR 99.9% CI OR 99.9% CI 
Wave 5 
 1. Self-health (Fair/Poor) 2.61 2.60-2.61* 3.26 3.22-3.31* H 2.56 2.55-2.57*  1.83 1.81-1.86* L 2.75 2.74-2.76*  
 2. Loneliness (Yes) 2.53 2.52-2.53* 2.59 2.56-2.62*  2.45 2.44-2.45*  2.16 2.14-2.20* L 2.71 2.70-2.72* H 
 3. ADL impaired (≥1) 2.38 2.37-2.39* 1.79 1.76-1.82* L 2.01 2.00-2.02*  2.41 2.37-2.44*  3.27 3.26-3.29* H 
 4. Gender (Female) 2.12 2.12-2.13* 1.95 1.92-1.97* L 1.95 1.95-1.96* L 2.29 2.26-2.33*  2.44 2.43-2.45* H 
 5. Financial (Difficulty) 1.63 1.62-1.63* 1.69 1.66-1.71*  1.45 1.45-1.46* L 1.59 1.57-1.61*  1.91 1.91-1.92* H 
 6. Chronic dis. (≥2) 1.49 1.48-1.49* 1.30 1.28-1.32* L 1.41 1.41-1.42*  1.36 1.34-1.38*  1.66 1.65-1.66* H 
 7. Cognition (<15) 1.46 1.45-1.46* 1.25 1.23-1.26* L 1.45 1.45-1.46*  1.69 1.67-1.72* H 1.42 1.41-1.43* 
 8.Schooling (<10) 1.19 1.18-1.19* 1.05 1.04-1.06*  1.26 1.25-1.26* H 1.03 1.02-1.05*  1.02 1.02-1.03* L 
 9. Age (≥75)  0.85 0.85-0.86* 0.95 0.94-0.97*  0.81 0.81-0.82* L 1.11 1.10-1.12* H 0.88 0.88-0.89* 
Wave 6 
 1. Self-health (Fair/Poor) 2.81 2.80-2.82* 2.87 2.84-2.91*  2.71 2.70-2.72*  2.37 2.34-2.41* L 3.08 3.07-3.09* H 
 2. Loneliness (Yes) 2.45 2.44-2.45* 2.47 2.44-2.50*  2.54 2.54-2.55*  2.67 2.63-2.70* H 2.30 2.29-2.31* L 
 3. Gender (Female) 2.03 2.02-2.03* 1.93 1.90-1.95* L 2.08 2.07-2.08*  2.40 2.36-2.43* H 1.96 1.95-1.97* 
 4. ADL impaired (≥1) 1.93 1.92-1.93* 2.27 2.23-2.30*  1.65 1.65-1.66* L 2.68 2.64-2.72* H 2.57 2.56-2.58* 
 5. Financial (Difficulty) 1.57 1.57-1.58* 1.45 1.43-1.47*  1.59 1.59-1.60* H 1.31 1.29-1.32* L 1.54 1.53-1.54* 
 6. Cognition (<15) 1.48 1.47-1.48* 1.26 1.24-1.27* L 1.43 1.43-1.44*  1.97 1.93-1.99* H 1.46 1.45-1.46* 
 7. Chronic dis. (≥2) 1.15 1.14-1.15* 1.24 1.23-1.26*  1.06 1.06-1.07* L 1.32 1.30-1.34* H 1.26 1.25-1.26*  
 8. Schooling (<10) 1.11 1.10-1.11* 0.80 0.79-0.81* L 1.11 1.10-1.11* H 1.04 1.03-1.06*  1.02 1.02-1.03* 
 9. Age (≥75)  1.02 1.01-1.02* 1.23 1.21-1.24* H 0.97 0.96-0.97*  0.96 0.94-0.97* L 1.07 1.07-1.08* 
Prevalence, %   
 EURO-D (≥4) W5 / W6 29.8 / 31.5 16.8 / 17.6  27.3 / 29.3  25.4 / 24.4  36.2 / 37.8 
Note. Dependent variable: EURO-D ≥4. Weighted data. OR, odds ratio; CI, confidence interval. *p < 0.001. Effect size for OR: small: <1.5, medium: 1.5-4.9, 














Table 4  
Predictors of incidence and remission of depressive symptoms in Wave 5. Binary multivariate logistic regression models.  
  All Cases  Northern Continental Eastern Southern 
  OR 99.9% CI OR 99.9% CI OR 99.9% CI OR 99.9% CI OR 99.9% CI 
Incidence vs. No-depression, n 2862 vs. 14205 311 vs. 2735 1057 vs. 5516 765 vs. 3306 729 vs. 2648  
 Gender (Female) 1.78 1.77-1.78* 1.55 1.53-1.58* L 1.74 1.73-1.74*  1.87 1.84-1.91*  1.95 1.94-1.96* H 
 Self-health (Fair/Poor) 1.67 1.66-1.67* 2.50 2.46-2.55* H 1.60 1.59-1.61*  1.47 1.45-1.50* L 1.77 1.76-1.78*  
 Loneliness  (Yes) 1.63 1.62-1.64* 1.54 1.51-1.56*  1.53 1.53-1.54* L 1.57 1.55-1.60*  1.80 1.79-1.80* H 
 Age (≥75)  1.44 1.43-1.44* 1.50 1.48-1.53* H 1.47 1.46-1.48*  1.19 1.18-1.22* L 1.45 1.44-1.46* 
 ADL impaired (≥1) 1.34 1.34-1.35* 1.19 1.16-1.22*  1.13 1.13-1.14* L 2.53 2.47-2.59* H 1.80 1.79-1.82*  
 Financial (Difficulty) 1.30 1.30-1.31* 0.87 0.85-0.89* L 1.33 1.33-1.34* H 1.08 1.07-1.11*  1.21 1.21-1.22*  
 Cognition (<15) 1.27 1.27-1.28* 1.17 1.15-1.19*  1.31 1.31-1.32* H 1.26 1.24-1.28*  1.03 1.02-1.04* L 
 Chronic dis. (≥2) 1.24 1.23-1.24* 1.32 1.30-1.35*  1.48 1.47-1.48* H 1.12 1.10-1.14*  0.99 0.98-0.99* L 
 Schooling (<10) 1.09 1.09-1.10* 0.78 0.77-0.80* L 1.04 1.03-1.04*  1.04 1.02-1.05*  1.09 1.08-1.10* H 
Persistence vs. No-depression, n  3618 vs. 14205 303 vs. 2735 1259 vs. 5516 1013 vs. 3306 1043 vs. 2648 
 Self-health (Fair/Poor) 3.73 3.72-3.75* 4.57 4.49-4.66* H 3.62 3.61-3.64*  2.89 2.83-2.95* L 4.07 4.05-4.10*  
 Loneliness  (Yes) 3.10 3.09-3.11* 3.04 2.99-3.10*  2.87 2.86-2.88* L 2.95 2.90-3.01*  3.59 3.57-3.61* H 
 ADL impaired (≥1) 2.90 2.89-2.91* 1.75 1.71-1.79* L 2.26 2.25-2.27*  4.31 4.22-4.40*  4.66 4.63-4.70* H 
 Gender (Female) 2.82 2.81-2.83* 2.48 2.44-2.53* L 2.54 2.53-2.55*  3.69 3.61-3.76* H 3.40 3.38-3.42*  
 Financial (Difficulty) 1.78 1.77-1.79* 1.95 1.91-1.99* H 1.70 1.69-1.71*  1.67 1.64-1.70* L 1.86 1.85-1.87*  
 Chronic dis. (≥2) 1.71 1.70-1.72* 1.42 1.39-1.44* L 1.64 1.63-1.65*  1.45 1.42-1.48*  1.91 1.90-1.92* H 
 Cognition (<15) 1.53 1.52-1.53* 1.33 1.31-1.35*  1.47 1.46-1.48*  1.96 1.92-2.00* H 1.49 1.48-1.50*  
 Schooling (<10) 1.34 1.34-1.35* 0.87 0.85-0.88* L 1.39 1.38-1.39* H 1.12 1.10-1.14*  1.18 1.17-1.19*  
 Age (≥75)  0.98 0.97-0.98* 1.16 1.14-1.19* H 0.91 0.90-0.91*  1.04 1.02-1.06*  1.09 1.08-1.09* 
Remission vs. Persistence, n 2516 vs. 3618 278 vs. 303 864 vs. 1259 717 vs. 1013 657 vs. 1043 
 Self-health (Good) 1.80 1.79-1.80* 1.59 1.56-1.63* L 1.83 1.82-1.84*  2.10 2.05-2.15* H 1.71 1.70-1.73*  
 Gender (Male) 1.51 1.50-1.52* 1.43 1.40-1.46* L 1.52 1.51-1.53*  2.19 2.14-2.24* H 1.49 1.47-1.49*  
 ADL impaired (No) 1.45 1.44-1.46* 1.03 1.00-1.06* L 1.34 1.33-1.34*  2.17 2.12-2.22* H 1.62 1.61-1.63*  
 Loneliness  (No) 1.39 1.38-1.39* 1.37 1.34-1.40*  1.33 1.32-1.34* L 1.36 1.33-1.39*  1.48 1.47-1.48* H 
 Chronic dis. (0-1) 1.16 1.15-1.16* 1.02 0.99-1.05† L 1.10 1.09-1.10*  1.02 0.99-1.04‡ L 1.27 1.27-1.28* H 
 Schooling (>10) 1.14 1.14-1.15* 0.79 0.77-0.81* L 1.13 1.13-1.14*  1.23 1.21-1.26* H 1.13 1.12-1.14*  
 Financial (No diff.) 1.13 1.13-1.14* 1.46 1.42-1.49* H 1.25 1.24-1.26*  1.11 1.09-1.14*  0.99 0.98-0.99* L 
 Age (<75)  1.10 1.10-1.11* 1.40 1.37-1.43* H 1.02 1.02-1.03*  0.91 0.89-0.93* L 1.23 1.22-1.23* 













Rates *100 persons-years 
 Incidence  6.62 6.61-6.63 4.93  4.89-4.96 6.27  6.26-6.28 6.04  6.00-6.08 7.43  7.42-7.45   H 
 Persistence 9.22 9.21-9.24 5.14 5.11-5.18 8.07 8.06-8.09 6.95 6.91-6.99 11.86 11.84-11.88 H 
 Remission 5.78 5.77-5.79 4.45 4.42-4.49 5.31 5.30-5.32 6.60 6.55-6.64  6.61 6.60-6.63 H 
Note. Binary variables = No depressive symptoms (0) vs. Incidence (1), No depressive symptoms (0) vs. Persistence (1), Persistence (0) vs. Remission (1). 
Weighted data. OR, odds ratio; CI, confidence interval (99.9 Poisson). *p < 0.001. Effect size for OR: small: <1.5, medium: 1.5-4.9, large: ≥5.0. Medium and 
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Figure 1. Flow chart describing the sample for the two-year follow-up study. Unweighted data. Clinically 
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